Home > Insider Trading > Filing (0001415889-24-023779)

Filing Details

Accession Number:: 0001415889-24-023779
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-20 16:45:32
Reporting Period:: 2024-09-18

Accepted Time:: 2024-09-20 16:45:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184592	C Beth Seidenberg	C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2024-09-18	1,177	$42.01	160,376	No	4	S	Direct
Class A Common Stock	Disposition	2024-09-18	1,476	$42.00	4,012	No	4	S	Indirect	See Footnote
Class A Common Stock	Disposition	2024-09-19	13,823	$42.31	146,553	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See Footnote
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 19, 2024.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.07, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
In prior reports, the Reporting Person reported indirect beneficial ownership of 1,949,295 shares of Class A Common Stock (the "Shares") held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and KPCB XVI Founders Fund, LLC ("XVI Founders"), whose managing member is KPCB XVI Associates, LLC ("XVI Associates"). On April 10, 2024, KPCB XVI and XVI Founders made a pro-rata in-kind distribution of 750,000 Shares without consideration to its members, including XVI Associates, and likewise on June 5, 2024, they made an additional pro-rata in-kind distribution of 1,199,295 Shares to its members, including XVI Associates.
On April 10, 2024, April 12, 2024, June 5, 2024 and June 13, 2024, the Reporting Person received an aggregate of 161,553 Shares as part of a pro-rata in-kind distribution without consideration from KPCB XVI, XVI Founders and their managing member, XVI Associates. The Reporting Person is one of the five managing members of XVI Associates.
On April 10, 2024 and June 5, 2024, an aggregate of 5,488 Shares were received as part of a pro-rata in-kind distribution without consideration from XVI Associates, the managing member of KPCB XVI and XVI Founders. The Reporting Person is one of the five managing members of XVI Associates.
Shares are held by the Samuel B. Seidenberg Irrevocable Trust, established on July 1, 2013, for which the Reporting Person and her spouse serve as trustees.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.79, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.